UGT1A1 Assay
Order Name
UGT1A1
Test Number: 9103375
Revision Date 09/17/2009
Test Number: 9103375
Revision Date 09/17/2009
| Test Name | Methodology | LOINC Code |
|---|---|---|
|
UGT1A1 Assay
|
Signal Amplification, Invader chemistry detection |
| SPECIMEN REQUIREMENTS | ||||
|---|---|---|---|---|
| Specimen | Specimen Volume (min) | Specimen Type | Specimen Container | Transport Environment |
| Preferred | 5 (3 mL) | Whole Blood | EDTA (Lavender Top) | Room Temperature |
| Instructions | Keep specimen as whole blood at room temperature. Do not centrifuge, do not refrigerate. Specimen cannot be shared with other testing for risk of DNA contamination. | |||
| GENERAL INFORMATION | |
|---|---|
| Testing Schedule | Assay Dependant |
| Expected TAT | 3-10 Day |
| Clinical Use | This is a pharmacogenomic assay for identifying subsets of patients at increased risk for toxicity to Irinotecan (CAMPTOSAR®). Irinotecan (CAMPTOSAR®) is used as part of a first line regimen in treating patients with metastatic colon or rectal carcinoma. |
| CPT Code(s) | 83891; 83896x20; 83892x8; 83903x4; 83912; 8391226 |
| Internal Comments | Deactivated in Sept 2009 due to low utilization - per Sonja Mathews |
| Service Provided By |  |
| Lab Section | Immunology - Serology |